Stage II Bladder Cancer AJCC v8

specific

Stage III includes: IIIA: (T3a, T3b, T4a, N0, M0); (T1-T4a, N1, M0); IIIB: (T1-T4a, N2, N3, M0). T1: Tumor invades lamina propria (subepithelial connective tissue). T2: Tumor invades muscularis propria. T3: Tumor invades perivesical soft tissue. T3a: Tumor invades perivesical soft tissue, microscopically. T3b: Tumor invades perivesical soft tissue, macroscopically (extravesical mass). T4a: Extravesical tumor invades directly into prostatic stroma, uterus, vagina. N0: No regional lymph node metas

61

Centers

103

Active Trials

Cancer Funding

Top Centers for Stage II Bladder Cancer AJCC v8(61)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
69.6
2
NCI Comprehensive
Active Research Program
69.6
3
NCI Comprehensive
Active Research Program
69.6
4
Active Research Program
69.6
5
NCI Comprehensive
Active Research Program
69.6
6
Active Research Program
69.6
7
Active Research Program
69.6
869.6
9
Active Research Program
69.6
10
Active Research Program
69.6
11
NCI Comprehensive
Active Research Program
57.8
12
NCI Comprehensive
Active Research Program
57.8
13
NCI Comprehensive
Active Research Program
57.8
14
NCI Comprehensive
Active Research Program
57.8
15
NCI Comprehensive
Active Research Program
57.8
16
NCI Comprehensive
Active Research Program
57.8
17
NCI Comprehensive
Active Research Program
57.8
18
NCI Comprehensive
Active Research Program
57.8
1957.8
20
NCI Comprehensive
Active Research Program
57.8
21
NCI Comprehensive
Active Research Program
57.8
22
NCI Comprehensive
Active Research Program
57.8
23
NCI Clinical
Active Research Program
57.8
24
NCI Comprehensive
Active Research Program
57.8
25
Active Research Program
57.8
26
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
57.8
27
NCI Comprehensive
Active Research Program
57.8
28
Active Research Program
57.8
29
Active Research Program
57.8
30
Active Research Program
57.8
31
Active Research Program
57.8
32
Active Research Program
57.8
33
NCI Comprehensive
Active Research Program
39.0
34
NCI Comprehensive
Active Research Program
39.0
35
NCI Comprehensive
Active Research Program
39.0
36
NCI Comprehensive
Active Research Program
39.0
37
NCI Comprehensive
Active Research Program
39.0
38
NCI Comprehensive
Active Research Program
39.0
39
NCI Comprehensive
Active Research Program
39.0
40
NCI Comprehensive
Active Research Program
39.0
41
NCI Comprehensive
Active Research Program
39.0
42
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
39.0
43
NCI Comprehensive
Active Research Program
39.0
44
NCI Comprehensive
Active Research Program
39.0
45
NCI Clinical
Active Research Program
39.0
46
NCI Comprehensive
Active Research Program
39.0
47
NCI Comprehensive
Active Research Program
39.0
48
NCI Comprehensive
Active Research Program
39.0
49
NCI Clinical
Active Research Program
39.0
50
NCI Clinical
Active Research Program
39.0
51
NCI Comprehensive
Active Research Program
39.0
52
NCI Clinical
Active Research Program
39.0
53
NCI Comprehensive
Active Research Program
39.0
54
Active Research Program
39.0
55
Active Research Program
39.0
56
Active Research Program
39.0
57
Active Research Program
39.0
58
Active Research Program
39.0
59
Active Research Program
39.0
60
Active Research Program
39.0
61
Active Research Program
39.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →